V. The Risk Management in Secondary Prevention for Atherosclerotic Cardiovascular Disease
Author:
Affiliation:
1. Department of Cardiovascular Biology and Medicine, Juntendo University
Publisher
Japanese Society of Internal Medicine
Link
https://www.jstage.jst.go.jp/article/naika/112/2/112_188/_pdf
Reference10 articles.
1. 1) 日本動脈硬化学会編: 動脈硬化性疾患予防ガイドライン2022年版. 東京, 2022.
2. 2) Hosomi N, et al: The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study. EBioMedicine 2: 1071-1078, 2015.
3. 3) Cannon CP, et al: Ezetimbe added to statin therapy after acute coronary syndromes. N Engl J Med 372: 2387-2397, 2015.
4. 4) Hagiwara N, et al: Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial. Eur Heart J 38: 2264-2276, 2017.
5. 5) Nakamura M, et al: Lipid Management and 2-year clinical outcomes in Japanese patients with acute coronary syndrome: EXPLORE-J. J Atheroscler Thromb 28: 1307-1322, 2021.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3